Skip to main content
. 2013 Oct 11;288(47):33571–33584. doi: 10.1074/jbc.M113.482364

FIGURE 9.

FIGURE 9.

A and B, hematocrit (A, HCT) and serum Epo (B) were measured in VE-cadh-Cre; Phd2f/f or Phd2f/f control mice (age = 5–6 months). No significant differences were found between the two groups by Student's t test (n = 4–7/group). C, survival analysis of VE-cadh-Cre; Phd2f/f or Phd2f/f control mice. Individuals were sacrificed for further analysis at 5–6 months of age and are indicated with overlaid symbols. D, heart weight of VE-cadh-Cre; Phd2f/for Phd2f/f control mice (age = 5–6 months). *, p < 0.05 relative to Phd2f/f controls by Student's t test.

HHS Vulnerability Disclosure